“The findings suggest that lifetime classic psychedelic use is associated with lower odds of having had heart disease or diabetes in the past year,” lead study author and Oxford sociologist Otto Simonsson.
Malaria has been one of the biggest scourges on humanity for millennia. Now, children across much of Africa are to be vaccinated against malaria in a historic moment in the fight against the deadly disease.
Studies from Columbia University, University of California Berkeley, and other renowned institutions show that chlorpyrifos can damage the developing brains of children, causing reduced IQ, loss of working memory, and attention deficit disorders.
The clinical trials will start on August 19 and end sometime around spring 2023, according to the National Institutes of Health’s trial registry. They will involve 56 HIV-negative participants aged 18 to 56.